DyDo GROUP HOLDINGS,INC. FY2027 Q2 Earnings Report

Financial Highlights

• Net Sales: ¥120.06B
• Operating Income: ¥6.74B
• Net Income: ¥2.89B
• EPS: ¥88.34

Income Statement

Balance Sheet

Cash Flow Statement

Profitability Ratios

Year-over-Year Comparison

Share Information

Dividend Information

Segment Information

Full Year Forecast

---

AI Financial Analysis

Executive Summary

FY2027 Q2 delivered a substantial earnings recovery, with operating income rebounding sharply despite only modest revenue growth. Revenue rose 2.0% year on year to ¥120.06bn. Operating income increased 388.2% to ¥6.74bn. Ordinary income rose from ¥0.69bn to ¥4.33bn, while profit attributable to owners recovered from a ¥1.36bn loss to ¥2.80bn. Gross profit increased 6.3% to ¥55.87bn, outpacing sales growth. The gross margin expanded by 164bp year on year to 46.5%. SG&A declined 4.5% to ¥49.12bn, reducing the SG&A-to-sales ratio by approximately 280bp to 40.9%. Consequently, the operating margin expanded by roughly 445bp to 5.6% from 1.2% in the prior-year period. International Beverage was the principal earnings engine, generating ¥5.23bn of segment operating income and a 14.5% margin. Domestic Beverage returned to profitability, although its revenue declined 5.5%. The Food and Pharmaceutical Related businesses remained profitable but showed marked earnings pressure, while DyDo Pharma remained loss-making. Earnings conversion into cash was weak: operating cash flow of ¥1.88bn represented only 0.67x net income and 0.20x EBITDA. Receivables and inventories increased by ¥5.83bn and ¥1.90bn respectively in the operating cash-flow bridge, constraining cash generation. Free cash flow was negative ¥0.97bn after ¥2.84bn of investing cash outflow, principally reflecting ¥6.24bn of purchases of property, plant and equipment and intangibles alongside securities investments. The balance sheet remains liquid, with a 171.2% current ratio, a 148.2% quick ratio and ¥24.10bn of cash and deposits. The full-year forecast implies that the first-half operating-income progress rate of 54.8% is modestly ahead of the normal 50% pace, whereas revenue progress is 48.7%. The revised forecast and first-half margin recovery make the earnings turnaround more credible, but the sustainability of the improvement depends on cash conversion, domestic beverage demand, and the durability of international beverage profitability.

Profitability Analysis

The reported 4.0% ROE is decomposed into a 2.3% net profit margin, 0.721x asset turnover and 2.39x financial leverage. The largest positive change was in profit margin, as operating-margin expansion to 5.6% drove the return from a prior-year net loss to ¥2.80bn of profit attributable to owners. Gross-margin expansion to 46.5% and lower SG&A were the principal operating drivers, with gross profit up ¥3.03bn and SG&A down ¥2.33bn. This indicates meaningful operating leverage: a ¥2.36bn revenue increase translated into a ¥5.36bn increase in operating income. The domestic beverage business swung from a ¥2.03bn segment loss to a ¥2.11bn profit despite a 5.5% sales decline, implying a significant improvement in cost structure and/or product mix. International Beverage reinforced the recovery, increasing sales 25.3% and segment operating income 68.0% to ¥5.23bn. However, consolidated net-margin quality remains modest at 2.3%, below the 5% level generally associated with strong profitability. Financial leverage of 2.39x supports ROE but is not excessive, while the underlying 2.3% net margin and 0.721x turnover limit the absolute return profile. The interest burden was 0.642, meaning the gap between EBIT of ¥6.74bn and profit before tax of ¥4.33bn was material; net non-operating expense totaled ¥2.41bn. Interest expense of ¥0.68bn was covered 9.96x by EBIT and 14.08x by EBITDA, so coverage remains sound, but the 0.642 interest-burden metric highlights that financing and other non-operating costs materially dilute operating earnings. Under JGAAP, goodwill amortization was ¥0.35bn; EBITDA before goodwill amortization was ¥9.88bn versus reported EBITDA of ¥9.53bn. Goodwill amortization represents only 3.5% of pre-goodwill-amortization EBITDA, so JGAAP goodwill accounting is not a material distortion of profitability.

Growth Assessment

Top-line growth was limited to 2.0%, and growth quality was mixed across the portfolio. International Beverage expanded revenue by 25.3% to ¥36.03bn and was the main growth driver. Its 14.5% segment margin was well above every other profitable segment, making its continued growth central to consolidated earnings momentum. Domestic Beverage, representing 56.3% of consolidated revenue, declined 5.5% to ¥67.62bn, leaving the group exposed to continued weakness in its largest revenue base. The segment's return to a 3.1% margin is encouraging, but this remains materially below International Beverage's profitability. Food sales fell 8.4% and segment operating income declined 93.4% to ¥0.04bn, reducing resilience in a category that would otherwise offer portfolio diversification. Pharmaceutical Related sales declined 6.4% and operating income fell 42.3%, while DyDo Pharma recorded a ¥0.80bn operating loss. Full-year guidance calls for revenue of ¥246.30bn, operating income of ¥12.30bn, ordinary income of ¥9.40bn and profit attributable to owners of ¥6.00bn. First-half progress is 48.7% for revenue, 54.8% for operating income, 46.1% for ordinary income and 46.7% for profit attributable to owners. None of these progress rates deviates by more than 10 percentage points from the standard 50% first-half benchmark. Operating profit is ahead of the normal first-half pace by 4.8 percentage points, while the lower ordinary-income and net-income progress rates reflect the substantial non-operating-cost burden. The company has revised its forecast, making subsequent execution against the revised targets a key indicator of management confidence and operational momentum.

Financial Health

Liquidity is sound. Current assets of ¥96.49bn exceeded current liabilities of ¥56.35bn, resulting in working capital of ¥40.14bn and a current ratio of 171.2%. The quick ratio of 148.2% indicates that liquidity is not dependent on inventory liquidation. Cash and deposits were ¥24.10bn, while short-term loans were only ¥0.05bn; cash covered short-term loans by 472.45x. The short-term debt ratio was 0.4%, limiting near-term refinancing and maturity-mismatch risk. Long-term loans were ¥13.22bn and bonds payable were ¥15.00bn, with current portions of long-term loans of ¥3.40bn classified within current liabilities. Reported interest-bearing debt was ¥13.27bn, equal to 1.39x EBITDA, and debt-to-capital was 16.0%, both consistent with manageable leverage. The reported debt-to-equity ratio was 1.39x, below the 2.0x threshold for aggressive leverage. Interest-servicing capacity is adequate, with EBIT interest coverage of 9.96x and EBITDA interest coverage of 14.08x. Equity increased to ¥69.77bn from ¥64.90bn, and the equity ratio improved to 41.5% from 39.5%. Goodwill of ¥4.64bn equaled only 6.7% of equity and 0.49x EBITDA, indicating limited balance-sheet dependence on acquired business values. Short-term loans increased from ¥0.06bn to ¥0.51bn, a 750.0% increase, but the absolute increase was only ¥0.45bn and remains immaterial relative to ¥24.10bn of cash. Defined-benefit liability was ¥2.39bn and should be considered within the broader noncurrent-obligation profile.

Notable B/S Changes

Short-term loans: +¥0.45bn (+750.0%) to ¥0.51bn - the percentage movement is large but the absolute balance remains immaterial relative to ¥24.10bn of cash and deposits. Foreign currency translation adjustment: improved by ¥3.01bn, from negative ¥1.70bn to positive ¥1.31bn - translation movements materially supported accumulated other comprehensive income and the increase in equity.

Cash Flow Quality

Cash-flow quality is the principal financial concern in the first half. Operating cash flow was ¥1.88bn, equivalent to 0.67x net income and below the 0.8x quality threshold. Cash conversion was also weak at 0.20x of EBITDA, substantially below the 0.7x alert threshold. The primary root cause was working-capital absorption: trade receivables increased by ¥5.83bn and inventories increased by ¥1.90bn. The quality alert for receivable days of 112 days is significant because it extends the period before reported revenue converts into cash and raises collection-execution risk. The inventory-day alerts of 108 days and 74 days indicate elevated stockholding relative to food-and-beverage benchmarks, increasing risks around inventory productivity, obsolescence and cash tied up in stock. Trade payables changed only marginally, falling ¥0.04bn, and therefore did not offset the cash investment in receivables and inventory. The accruals ratio of 0.6% is low and does not itself signal aggressive accrual accounting, but it does not negate the operational cash-conversion weakness. Investing cash flow was negative ¥2.84bn, including ¥6.24bn spent on property, plant and equipment and intangibles, ¥3.70bn spent on short-term investment securities and ¥2.05bn spent on investment securities, partly offset by redemptions and time-deposit movements. Free cash flow was negative ¥0.97bn. Financing cash flow was negative ¥3.43bn, reflecting ¥2.26bn of long-term-loan repayments, ¥0.73bn of lease-obligation repayments and ¥0.48bn of cash dividends. Cash and cash equivalents declined by ¥4.54bn to ¥23.33bn. Sustained improvement in collections and inventory discipline is needed for operating earnings to translate into internally funded investment and shareholder distributions.

Dividend Sustainability

The Q2 dividend was ¥15.00 per share, matching the prior-year interim dividend and consistent with the ¥30.00 per-share full-year forecast. The calculated dividend payout ratio is 17.8%, which is conservative relative to first-half earnings and provides considerable accounting-profit coverage. However, free cash flow was negative ¥0.97bn and the stated FCF coverage was negative 1.95x, so first-half dividends were not covered by free cash generation after investment spending. Cash dividends paid were ¥0.48bn, which was modest relative to the ¥24.10bn cash balance and the group's liquidity headroom. The sustainability of the ¥30.00 annual dividend therefore rests on recovery in second-half operating cash flow and disciplined capital expenditure rather than on payout ratio alone. The low payout ratio provides flexibility if working-capital investment persists, but elevated receivable and inventory days remain the primary variables affecting cash-funded dividend capacity.

Risk Assessment

Business risks include Domestic Beverage concentration: the segment accounts for 56.3% of revenue, yet Q2 sales declined 5.5%. A further demand, channel, pricing or vending-machine-volume downturn would have a material effect on group revenue., International Beverage dependence: International Beverage generated ¥5.23bn of segment operating income, approximately 69% of aggregate segment profit, and its 14.5% margin is far above the rest of the portfolio. This concentration increases sensitivity to overseas demand, foreign exchange, local competition and execution., Food-industry cost and inventory risk: elevated inventory days of 108 days and 74 days increase exposure to product obsolescence, slow-moving stock, raw-material volatility, packaging and logistics inflation, and food-safety or recall events., Portfolio underperformance: Food segment profit declined 93.4%, Pharmaceutical Related profit declined 42.3%, and DyDo Pharma remained loss-making, creating risk that turnaround resources dilute consolidated returns..

Financial risks include Earnings-to-cash divergence: OCF/Net Income of 0.67x and OCF/EBITDA of 0.20x indicate that first-half reported earnings were not fully realized in cash., Working-capital risk: DSO of 112 days and elevated inventory days reflect substantial capital tied up in receivables and inventory; receivables rose ¥5.83bn and inventories rose ¥1.90bn in the cash-flow bridge., Non-operating-cost burden: the 0.642 interest burden means that net non-operating expenses reduced EBIT of ¥6.74bn to profit before tax of ¥4.33bn. Interest coverage is sound, but this dilution constrains net-income conversion., Investment funding risk: negative ¥0.97bn free cash flow, combined with ¥2.84bn of investing outflows, reduced cash and cash equivalents by ¥4.54bn..

Key concerns include Highest priority is normalization of working capital, particularly collection days and inventory productivity, because these factors directly determine whether the earnings recovery becomes self-funding., Second is sustaining domestic beverage profitability while restoring sales growth; the segment recovered its margin but remains the largest revenue exposure., Third is validating that International Beverage's strong 14.5% margin and 25.3% sales growth can remain durable rather than being offset by lower-margin or loss-making businesses., The short-term-loan balance rose 750.0% year on year, but the ¥0.45bn absolute increase is small and does not presently alter the low near-term refinancing-risk assessment..

Investment Implications

Key takeaways include The quarter demonstrates a clear operating turnaround: revenue grew 2.0%, but operating income increased 388.2% through gross-margin expansion and lower SG&A., International Beverage is the core business by operating-income contribution, with ¥36.03bn of sales, ¥5.23bn of operating income and a 14.5% margin., The balance sheet has ample liquidity and moderate credit leverage, with a 171.2% current ratio, 1.39x debt/EBITDA and 14.08x EBITDA interest coverage., Cash conversion is the principal counterweight to improved earnings: OCF/Net Income was 0.67x, cash conversion was 0.20x, and free cash flow was negative., The interim dividend appears conservatively sized relative to accounting earnings, but its cash funding depends on second-half working-capital normalization..

Metrics to watch include Domestic Beverage revenue trend and segment operating margin, International Beverage sales growth and sustainability of its 14.5% segment margin, DSO of 112 days and the movement in trade receivables, Inventory days of 108 days and 74 days, together with inventory cash absorption, OCF/Net Income ratio, OCF/EBITDA cash conversion and free cash flow, Progress versus full-year forecasts for operating income, ordinary income and profit attributable to owners, Food, Pharmaceutical Related and DyDo Pharma segment profitability.

Regarding relative positioning, The group combines a strong gross margin of 46.5% with a still-modest 5.6% consolidated operating margin and 2.3% net margin. Its liquidity, debt/EBITDA and goodwill exposure compare favorably with conservative balance-sheet benchmarks, while cash conversion and working-capital efficiency are weaker than desirable for a consumer-products and beverage business. International Beverage provides a high-margin differentiator, whereas declining domestic beverage sales and weak non-beverage segment earnings constrain portfolio balance.